Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 137

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Machine learning-guided discovery and design of non-hemolytic peptides

Plisson, Fabien, Ramírez-Sánchez, Obed, Martínez-Hernández, Cristina·2020·Scientific Reports

Abstract

Reducing hurdles to clinical trials without compromising the therapeutic promises of peptide candidates becomes an essential step in peptide-based drug design. Machine-learning models are cost-effective and time-saving strategies used to predict biological activities from primary sequences. Their limitations lie in the diversity of peptide sequences and biological information within these models. Additional outlier detection methods are needed to set the boundaries for reliable predictions; the applicability domain. Antimicrobial peptides (AMPs) constitute an extensive library of peptides offering promising avenues against antibiotic-resistant infections. Most AMPs present in clinical trials are administrated topically due to their hemolytic toxicity. Here we developed machine learning models and outlier detection methods that ensure robust predictions for the discovery of AMPs and the design of novel peptides with reduced hemolytic activity. Our best models, gradient boosting classifiers, predicted the hemolytic nature from any peptide sequence with 95–97% accuracy. Nearly 70% of AMPs were predicted as hemolytic peptides. Applying multivariate outlier detection models, we found that 273 AMPs (~ 9%) could not be predicted reliably. Our combined approach led to the discovery of 34 high-confidence non-hemolytic natural AMPs, the de novo design of 507 non-hemolytic peptides, and the guidelines for non-hemolytic peptide design.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41598-020-73644-6

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 57

  1. Fosgerau, K. & Hoffmann, T. Peptide therapeutics: current status and future directions. Drug Discov. Today 20, 122–128 (2015). · DOI · Paper page
  2. Haney, E. F., Straus, S. K. & Hancock, R. E. W. Reassessing the host defense peptide landscape. Front. Chem. 7, 1–22 (2019). · DOI · Paper page
  3. Fernández de Ullivarri, M., Arbulu, S., Garcia-Gutierrez, E. & Cotter, P. D. Antifungal peptides as therapeutic agents. Front. Cell. Infect. Microbiol. 10, 105 (2020). · DOI · Paper page
  4. Nyanguile, O. Peptide antiviral strategies as an alternative to treat lower respiratory viral infections. Front. Immunol. 10, 1366 (2019). · DOI
  5. Lacerda, A. F., Pelegrini, P. B., de Oliveira, D. M., Vasconcelos, ÉA. R. & Grossi-de-Sá, M. F. Anti-parasitic peptides from arthropods and their application in drug therapy. Front. Microbiol. 7, 1–11 (2016). · DOI
  6. Windley, M. J. et al. Spider-venom peptides as bioinsecticides. Toxins (Basel) 4, 191–227 (2012). · DOI · Paper page
  7. Gabernet, G., Müller, A. T., Hiss, J. A. & Schneider, G. Membranolytic anticancer peptides. Medchemcomm 7, 2232–2245 (2016). · DOI
  8. McGregor, D. Discovering and improving novel peptide therapeutics. Curr. Opin. Pharmacol. 8, 616–619 (2008). · DOI · Paper page
  9. Lin, Y., Cai, Y., Liu, J., Lin, C. & Liu, X. An advanced approach to identify antimicrobial peptides and their function types for penaeus through machine learning strategies. BMC Bioinform. 20, 1–10 (2019). · DOI · Paper page
  10. Cardoso, M. H. et al. Computer-aided design of antimicrobial peptides: are we generating effective drug candidates?. Front. Microbiol. 10, 1–15 (2020). · DOI · Paper page
  11. Speck-Planche, A., Kleandrova, V. V., Ruso, J. M. & Dias Soeiro Cordeiro, M. N. First multitarget chemo-bioinformatic model to enable the discovery of antibacterial peptides against multiple gram-positive pathogens. J. Chem. Inf. Model. 56, 588–598 (2016). · DOI
  12. Kleandrova, V. V., Ruso, J. M., Speck-Planche, A. & Dias Soeiro Cordeiro, M. N. Enabling the discovery and virtual screening of potent and safe antimicrobial peptides. Simultaneous prediction of antibacterial activity and cytotoxicity. ACS Comb. Sci. 18, 490–498 (2016). · DOI
  13. Munteanu, C. R. et al. Improvement of epitope prediction using peptide sequence descriptors and machine learning. Int. J. Mol. Sci. 20, 4362 (2019). · doi:10.3390/ijms20184362
  14. Shoombuatong, W., Schaduangrat, N. & Nantasenamat, C. Unraveling the bioactivity of anticancer peptides as deduced from machine learning. EXCLI J. 17, 734–752 (2018).
  15. Gabernet, G. et al. In silico design and optimization of selective membranolytic anticancer peptides. Sci. Rep. 9, 11282 (2019). · DOI
  16. Speck-Planche, A. & Cordeiro, M. N. D. S. Speeding up the virtual design and screening of therapeutic peptides, in Multi-Scale Approaches in Drug Discovery. 127–147. (Elsevier, Amsterdam, 2017). · DOI
  17. Win, T. S. et al. HemoPred: a web server for predicting the hemolytic activity of peptides. Future Med. Chem. 9, 275–291 (2017). · DOI
  18. Chaudhary, K. et al. A web server and mobile app for computing hemolytic potency of peptides. Sci. Rep. 6, 22843 (2016). · DOI · Paper page
  19. Kawashima, S., Ogata, H. & Kanehisa, M. AAindex: amino acid index database. Nucleic Acids Res. 27, 368–369 (1999). · DOI · Paper page
  20. Hasan, M. M. et al. HLPpred-Fuse: improved and robust prediction of hemolytic peptide and its activity by fusing multiple feature representation. Bioinformatics 36, 3350–3356 (2020). · DOI · Paper page
  21. Timmons, P. B. & Hewage, C. M. HAPPENN is a novel tool for hemolytic activity prediction for therapeutic peptides which employs neural networks. Sci. Rep. 10, 10869 (2020). · DOI
  22. Gautam, A. et al. Hemolytik: a database of experimentally determined hemolytic and non-hemolytic peptides. Nucleic Acids Res. 42, D444–D449 (2014). · DOI · Paper page
  23. Jungo, F., Bougueleret, L., Xenarios, I. & Poux, S. The UniProtKB/Swiss-Prot Tox-Prot program: a central hub of integrated venom protein data. Toxicon 60, 551–557 (2012). · DOI · Paper page
  24. Pirtskhalava, M. et al. DBAASP vol 2: an enhanced database of structure and antimicrobial/cytotoxic activity of natural and synthetic peptides. Nucleic Acids Res. 44, D1104–D1112 (2016). · DOI · Paper page
  25. Wang, G., Li, X. & Wang, Z. APD3: the antimicrobial peptide database as a tool for research and education. Nucleic Acids Res. 44, D1087–D1093 (2016). · DOI · Paper page
  26. Tharwat, A. Linear vs. quadratic discriminant analysis classifier: a tutorial. Int. J. Appl. Pattern Recognit. 3, 145 (2016). · DOI · Paper page
  27. Breiman, L., Friedman, J. H., Stone, C. J. & Olshen, R. A. Classification and Regression Trees. The Wadsworth and Brooks-Cole Statistics-Probability Series Wadsworth Statistics/Probability Series (Taylor & Francis, Abingdon, 1984).
  28. Breiman, L. Random forests. Mach. Learn. 45, 5–32 (2001). · DOI · Paper page
  29. Friedman, J. H. Machine. Ann. Stat. 29, 1189–1232 (2001). · DOI · Paper page
  30. Pedregosa, F. et al. Scikit-learn: machine learning in Python. J. Mach. Learn. Res. 12, 2825–2830 (2011).
  31. Johnsson, T. A procedure for stepwise regression analysis. Stat. Pap. 33, 21–29 (1992). · doi:10.1007/bf02925308
  32. Alin, A. Multicollinearity. Wiley Interdiscip. Rev. Comput. Stat. 2, 370–374 (2010). · DOI · Paper page
  33. He, Z., Xu, X. & Deng, S. Discovering cluster-based local outliers. Pattern Recognit. Lett. 24, 1641–1650 (2003). · DOI · Paper page
  34. Peng, Y. & Biao, H. KNN based outlier detection algorithm in large dataset. In 2008 International Workshop on Education Technology and Training & 2008 International Workshop on Geoscience and Remote Sensing, ETT GRS, vol 1, 611–613 (2008).
  35. Lazarevic, A. & Kumar, V. Feature bagging for outlier detection. In Proceedings of the ACM SIGKDD International Conferenceon Knowledge Discovery and Data Mining, 157–166 (2005). · DOI · Paper page
  36. Zhao, Y., Nasrullah, Z. & Li, Z. PyOD: a python toolbox for scalable outlier detection. J. Mach. Learn. Res. 20, 1–7 (2019).
  37. Lee, J. A., Peluffo-Ordóñez, D. H. & Verleysen, M. Multi-scale similarities in stochastic neighbour embedding: reducing dimensionality while preserving both local and global structure. Neurocomputing 169, 246–261 (2015). · DOI
  38. Kraemer, G., Reichstein, M. & Mahecha, M. D. dimRed and coRanking-unifying dimensionality reduction in R. R J. 10, 342 (2018). · DOI
  39. Van Der Maaten, L. & Hinton, G. Visualizing data using t-SNE. J. Mach. Learn. Res. 9, 2579–2605 (2008).
  40. Moore, M. L. Medicinal chemistry. Ind. Eng. Chem. 43, 577–588 (1951). · doi:10.1021/ie50495a015
  41. Bartels, E. J. H., Dekker, D. & Amiche, M. Dermaseptins, multifunctional antimicrobial peptides: a review of their pharmacology, effectivity, mechanism of action, and possible future directions. Front. Pharmacol. 10, 1–11 (2019). · DOI
  42. Zhou, J. G. et al. Molecular cloning and characterization of two novel hepcidins from orange-spotted grouper, Epinephelus coioides. Fish Shellfish Immunol. 30, 559–568 (2011). · DOI
  43. Sitaram, N., Subbalakshmi, C., Krishnakumari, V. & Nagaraj, R. Identification of the region that plays an important role in determining antibacterial activity of bovine seminalplasmin. FEBS Lett. 400, 289–292 (1997). · doi:10.1016/s0014-5793(96)01406-8
  44. Li, J. et al. Anti-infection peptidomics of amphibian skin. Mol. Cell. Proteomics 6, 882–894 (2007). · DOI · Paper page
  45. Conlon, J. M. et al. Host defense peptides in skin secretions of the Oregon spotted frog Rana pretiosa: implications for species resistance to chytridiomycosis. Dev. Comp. Immunol. 35, 644–649 (2011). · doi:10.1016/j.dci.2011.01.017
  46. Marani, M. M. et al. Characterization and biological activities of ocellatin peptides from the skin secretion of the frog leptodactylus pustulatus. J. Nat. Prod. 78, 1495–1504 (2015). · doi:10.1021/np500907t
  47. Zohrab, F., Askarian, S., Jalili, A. & Kazemi Oskuee, R. Biological properties, current applications and potential therapeautic applications of brevinin peptide superfamily. Int. J. Pept. Res. Ther. 25, 39–48 (2019). · DOI
  48. Lai, R. et al. Antimicrobial peptides from skin secretions of Chinese red belly toad Bombina maxima. Peptides 23, 427–435 (2002). · DOI · Paper page
  49. Zhang, X.-J. et al. Distinctive structural hallmarks and biological activities of the multiple cathelicidin antimicrobial peptides in a primitive teleost fish. J. Immunol. 194, 4974–4987 (2015). · DOI
  50. Couillault, C. et al. TLR-independent control of innate immunity in Caenorhabditis elegans by the TIR domain adaptor protein TIR-1, an ortholog of human SARM. Nat. Immunol. 5, 488–494 (2004). · DOI · Paper page
  51. Lim, M.-P., Firdaus-Raih, M. & Nathan, S. Nematode peptides with host-directed anti-inflammatory activity rescue Caenorhabditis elegans from a Burkholderia pseudomallei infection. Front. Microbiol. 7, 1436 (2016).
  52. Kumar, V., Kumar, R., Agrawal, P., Patiyal, S. & Raghava, G. P. S. A method for predicting hemolytic potency of chemically modified peptides from its structure. Front. Pharmacol. 11, 1–8 (2020). · DOI · Paper page
  53. Seelig, J. Thermodynamics of lipid-peptide interactions. Biochim. Biophys. Acta Biomembr. 1666, 40–50 (2004). · DOI · Paper page
  54. Guimarães, C. R. W., Mathiowetz, A. M., Shalaeva, M., Goetz, G. & Liras, S. Use of 3D properties to characterize beyond rule-of-5 property space for passive permeation. J. Chem. Inf. Model. 52, 882–890 (2012). · DOI
  55. Tropsha, A. Best practices for QSAR model development, validation, and exploitation. Mol. Inform. 29, 476–488 (2010). · DOI · Paper page
  56. Zheng, S. et al. In silico prediction of hemolytic toxicity on the human erythrocytes for small molecules by machine-learning and genetic algorithm. J. Med. Chem. 63, 6499–6512 (2020). · DOI
  57. Zheng, S. et al. Quantitative prediction of hemolytic toxicity for small molecules and their potential hemolytic fragments by machine learning and recursive fragmentation methods. J. Chem. Inf. Model. 60, 3231–3245 (2020). · DOI

Cited by

See all 137

Metadata

Authors
Plisson, F., Ramírez-Sánchez, O., & Martínez-Hernández, C.
Venue
Scientific Reports
Published
2020-10-06
Volume
10
Issue
1
ISSN
2045-2322
Cited by
137
References
11
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Machine learning-guided discovery and design of non-hemolytic peptides. https://app.cochat.ai/papers/10.1038/s41598-020-73644-6
The paper
Plisson, F., Ramírez-Sánchez, O., & Martínez-Hernández, C. (2020). Machine learning-guided discovery and design of non-hemolytic peptides. Scientific Reports. https://doi.org/10.1038/s41598-020-73644-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.